Dr. Panos Kottaridis
Consultant Haematologist in Leukaemia and BMT, Department of Haematology, University College London Hospitals. Leukaemia Lead, University College London Hospitals
Medical Director HCAHealthcare UK at University College London Hospitals, London, UK
Panos Kottaridis, MSc, PhD, FRCPath, is a consultant haematologist in leukaemia and BMT at University College London Hospitals NHS Foundation Trust. His main academic and clinical interests focus on prognostication of AML, BMT, Late Effects of chemotherapy, and Infertility in chemotherapy and stem cell recipients.
He is a member of the National Cancer Research Institute (former Medical Research Council) working party for AML and has published more than 80 papers in peer-reviewed journals; more than 4000 scientific papers have cited his work. Panos Kottaridis has also contributed to two chapters in haematology textbooks. He is an enthusiastic teacher and lecturer.
Under his capacity as the Medical director at HCAHealthcare at UCLH, he has promoted collaboration with various centres in the UK and Internationally and has built strong links with academia and Pharma, developing a network for safe delivery of clinical services as well as early and advanced Phase clinical trials.
